Wu Luo

机构：Shanghai Medical College of Fudan University, Fudan University, Sir Run Run Shaw Hospital, Fudan University Shanghai Cancer Center, Zhejiang University · ORCID：0000-0001-7383-9470

发表论文 126 篇 · 总被引 3483 次 · h-index 31

代表论文

Isolinderalactone attenuates atherosclerosis through inhibiting NF-κB-mediated inflammation in macrophages (2025 · International Immunopharmacology · 被引 3)
Correction: N6‑methyladenosine‑modified TRAF1 promotes sunitinib resistance by regulating apoptosis and angiogenesis in a METTL14‑dependent manner in renal cell carcinoma (2026 · Molecular Cancer · 被引 1)
Additional file 17 of Multi-omics analysis of patient-derived organoids reveals that E3 ligase COP1 promotes liver metastasis and oxaliplatin resistance in colorectal cancer through LUZP1 degradation and MYL9 phosphorylation (2026 · Figshare)
Multi-omics analysis of patient-derived organoids reveals that E3 ligase COP1 promotes liver metastasis and oxaliplatin resistance in colorectal cancer through LUZP1 degradation and MYL9 phosphorylation (2026 · Experimental Hematology and Oncology)
Additional file 17 of Multi-omics analysis of patient-derived organoids reveals that E3 ligase COP1 promotes liver metastasis and oxaliplatin resistance in colorectal cancer through LUZP1 degradation and MYL9 phosphorylation (2026 · Figshare)
Tumor Organoid and Microenvironment Cocultures: Implications for Basic and Translational Cancer Research (2026 · MedComm)